Fluorescence in situ hybridization is a current technique to detect chromosomal specific genetic disorders specific to urinary bladder cancer (UBC). This technique may be used to diagnose UBC, to follow up patients after surgical treatment, to evaluate the efficiency of adjuvant therapy in these patients, and to predict the development of disease recurrence
Kidney-sparing surgery of upper tract urothelial carcinoma (UTUC) requires a stringent follow-up wit...
PURPOSE: The objective of this study was to assess the value of fluorescence in situ hybridization t...
In the present study, different stages of transitional cell carcinoma of the bladder were analyzed b...
<p>Fluorescence in situ hybridization (FISH) assay was used to detect tumor cells in the urine sedim...
The authors report on their first experiences with the UroVysion fluorescence in situ hybridization ...
Objective: To evaluate the diagnostic value of fluorescence in situ hybridization (FISH) in bladder ...
<p>A sample of 63 patients with bladder cancer (BC) was used to estimate the informative value of a ...
Tumor markers for diagnosis of bladder cancer and defining the prognosis of the disease have been ac...
The newly developed UroVysion fluorescence in situ hybridization (FISH) probe was applied to urine s...
To assess the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasiv...
Aim: To evaluate the potential contribution of a fluorescent in situ hybridization (FISH) as prognos...
A multiprobe interphase fluorescence in situ hybridization (I-FISH) approach has become a useful a...
Bladder cancer is the fourth most common cancer in men and the fifth most common cancer worldwide. U...
Bladder cancer is the fourth most common cancer in men and the fifth most common cancer worldwide. U...
Background: Fluorescence in situ hybridization (FISH) has become a popular biomarker for subsequent ...
Kidney-sparing surgery of upper tract urothelial carcinoma (UTUC) requires a stringent follow-up wit...
PURPOSE: The objective of this study was to assess the value of fluorescence in situ hybridization t...
In the present study, different stages of transitional cell carcinoma of the bladder were analyzed b...
<p>Fluorescence in situ hybridization (FISH) assay was used to detect tumor cells in the urine sedim...
The authors report on their first experiences with the UroVysion fluorescence in situ hybridization ...
Objective: To evaluate the diagnostic value of fluorescence in situ hybridization (FISH) in bladder ...
<p>A sample of 63 patients with bladder cancer (BC) was used to estimate the informative value of a ...
Tumor markers for diagnosis of bladder cancer and defining the prognosis of the disease have been ac...
The newly developed UroVysion fluorescence in situ hybridization (FISH) probe was applied to urine s...
To assess the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasiv...
Aim: To evaluate the potential contribution of a fluorescent in situ hybridization (FISH) as prognos...
A multiprobe interphase fluorescence in situ hybridization (I-FISH) approach has become a useful a...
Bladder cancer is the fourth most common cancer in men and the fifth most common cancer worldwide. U...
Bladder cancer is the fourth most common cancer in men and the fifth most common cancer worldwide. U...
Background: Fluorescence in situ hybridization (FISH) has become a popular biomarker for subsequent ...
Kidney-sparing surgery of upper tract urothelial carcinoma (UTUC) requires a stringent follow-up wit...
PURPOSE: The objective of this study was to assess the value of fluorescence in situ hybridization t...
In the present study, different stages of transitional cell carcinoma of the bladder were analyzed b...